본문으로 건너뛰기
← 뒤로

Large-Scale Quantitative Morphometry of Platelet α-Granules via SIM Super-Resolution Microscopy for Cancer Liquid Biopsy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 p. e75094

Ma Y, Deng H, Liu Z, Zhong S, Wang L, He M, Jing N, Dai L, Basang Y, Hu XY, Zhang C, Zeng H, Shao H, Yang Z, Zhao S, Hu X, Zhang C, Wu X, Xu J, Zeng S, Yuan J, Li Q, Qu Z, Hong Z, Chen L, Dong H, Guo J, Han Z, Zhang YH

📝 환자 설명용 한 줄

Blood-based liquid biopsies hold transformative potential for non-invasive cancer management, but current approaches relying on rare circulating tumor components limit their broad clinical utility.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 표본수 (n) 1,556
  • Sensitivity 90.3%

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Ma Y, Deng H, et al. (2026). Large-Scale Quantitative Morphometry of Platelet α-Granules via SIM Super-Resolution Microscopy for Cancer Liquid Biopsy.. Advanced science (Weinheim, Baden-Wurttemberg, Germany), e75094. https://doi.org/10.1002/advs.75094
MLA Ma Y, et al.. "Large-Scale Quantitative Morphometry of Platelet α-Granules via SIM Super-Resolution Microscopy for Cancer Liquid Biopsy.." Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026, pp. e75094.
PMID 41961212
DOI 10.1002/advs.75094

Abstract

Blood-based liquid biopsies hold transformative potential for non-invasive cancer management, but current approaches relying on rare circulating tumor components limit their broad clinical utility. Platelets, abundant in blood and mediating diverse cancer-associated responses, represent a compelling yet largely unexplored alternative. Using SIM super-resolution microscopy, we analyzed α-granule distributions in platelets from a multicenter cohort (n = 1,556) encompassing nine cancer types and twelve non-malignant diseases. We identified robust cancer-associated alterations, particularly a marked increase in the "Circle" pattern, which exhibits excellent multi-cancer diagnostic potential. This method, termed PAID (Platelet Alpha-granule Imaging-based Diagnostic assay), achieved 85.0% accuracy in prostate cancer within the diagnostically challenging PSA "gray zone". PAID combined with PSA improved diagnostic accuracy to 94.2%, 38.4% over PSA alone, suggesting significant synergy. In ovarian cancer, PAID combined with HE4 enhanced diagnostic accuracy from 73.8% to 88.3%. Furthermore, PAID outperformed CA125 in sensitivity (90.3% vs 60.0%) for detecting ovarian cancer recurrence. We also observed that tumor cells may utilize both tumor-derived exosomes and proteins to remodel platelet α-granule distributions, suggesting the increased "Circle" pattern arises from synergistic rather than singular triggers. The non-invasive, highly accurate PAID shows great promise in advancing liquid biopsy for cancer management.

같은 제1저자의 인용 많은 논문 (5)